Novo Nordisk stock, once the darling of the pharmaceutical world, tumbled as investors reacted to a “worst-case scenario.”
Novo Nordisk Tumbles in ‘Worst Case Scenario’: Next-Gen Weight Loss Drug Underperforms
Importance Rank:
1